Did Cancer Drug Partnership Just Shift Gilead's (GILD) Investment Narrative?
Simply Wall Street
2026-10-17T21:43:53Z
$285.42 (0.71%)
Look this symbol up in Slack with /ticker ABBV. How to get stock tickers in Slack.
About AbbVie Inc
Healthcare
Loading chart…
Key Data
OPEN
$283.61
DAY RANGE
$282.95 - $286.64
52 WEEK RANGE
$188.25 - $291.4
MARKET CAP
$504370659000
VOLUME
5776793
AVERAGE VOLUME
Performance
Trade Day Range
$282.95
LOW
$286.64
HIGH
52 Week Range
$188.25
LOW
$291.4
HIGH
Trade Now
Using this link to sign up for Robinhood
Using this link to sign up for M1 Finance
Or this link to sign up for WeBull
Recent News
Insiders Sold EyePoint At US$15.75, Meanwhile Stock Sits Near US$2.99
Simply Wall Street
2026-10-17T12:43:17Z
AbbVie’s Dividend Keeps Climbing. Is It Still a Buy for Income Investors?
24/7 Wall St.
2026-10-17T12:07:56Z
NEXGEL (NASDAQ:NXGL) Share Price | RNS News, Quotes, & Charts | NXGL |
Proactive financial news
2026-10-17T09:42:17Z
Forget High-Yield Traps: AbbVie Is the Dividend King to Buy and Hold Through Any Rate Cycle
The Motley Fool
2026-10-17T09:02:38Z
U.S. IPO Weekly Recap: Biotechs City Therapeutics And Iambic Headline The Week's Pricings
Seeking Alpha
2026-10-17T04:13:26Z
Alvotech (ALVO) Climbed, But What Is Behind The Latest Attention?
Simply Wall Street
2026-10-17T01:12:51Z
Biogen (BIIB) On Lupus Trial Results Looks Fully Valued Or Still Worth Buying
Simply Wall Street
2026-10-16T21:58:11Z
Get ABBV quotes in Slack with /ticker ABBV.
